Accelerated Access: How FDA Breakthrough Therapy Is Transforming Drug Development
The Breakthrough Therapy BT Designation Market is experiencing robust growth as FDA breakthrough therapy continues to transform drug development and patient access. According to market reports, the global Breakthrough Therapy BT Designation Market was valued at USD 7.3 billion in 2024 and is projected to reach USD 25.0 billion by 2035, exhibiting a CAGR of 11.8% during the forecast...
0 Comments 0 Shares 466 Views 0 Reviews